with respect to my previous one:
I was also surprised to see that Peter wrote that the oppositions were to be
filed with the national patent offices. As you say it is centrally filed
with EPO, provided it is within the 9 month time frame.
With respect to EP702555, both Lilly and Icos filed their opposition on
101298 and 251298 respectively, along with other companies, before the 9
month deadline from 110398, the date of grant. But filing opposition does
not preclude anybody opposing in the national courts of the designated
countries and presumably Lilly/Icos exercised this option.
Swami
(S. narayanaswami)
Pfizer Global Research and development
Sandwich
Kent
CT13 9NJ
e-mail subramaniyan_naraynaswami@sandwich.pfizer.com
There was an error in the date: please read 251198 instead of 251298.
Swami
LEGAL NOTICE
Unless expressly stated otherwise, this message is confidential and
may be privileged. It is intended for the addressee(s) only. Access to
this e-mail by anyone else is unauthorised. If you are not an
addressee, any disclosure or copying of the contents of this e-mail or
any action taken (or not taken) in reliance on it is unauthorised and
may be unlawful. If you are not an addressee, please inform the sender
immediately.
Pfizer Limited is registered in England under No. 526209 with its
registered office at Ramsgate Road, Sandwich, Kent CT13 9NJ
PFIZER GLOBAL RESEARCH AND DEVELOPMENT
----------------------------------------------------------------
This message and any attachment has been virus checked by the
PGRD Sandwich Data Centre.
----------------------------------------------------------------
This archive was generated by hypermail 2b29 : Fri Aug 10 2001 - 15:59:05 EDT